Cargando…
Aldehyde dehydrogenase 1 as a predictor of the neoadjuvant chemotherapy response in breast cancer: A meta-analysis
BACKGROUND: Many reports suggest that aldehyde dehydrogenase 1 (ALDH1) expression is associated with poorer neoadjuvant chemotherapy (NAC) response in patients with breast cancer; however, the prognostic value of this enzyme in cancer has yet to be confirmed. Therefore, we conducted a meta-analysis...
Autores principales: | Li, Jie, Zhang, Bo, Yang, Yan Fang, Jin, Jian, Liu, Yong Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112948/ https://www.ncbi.nlm.nih.gov/pubmed/30142860 http://dx.doi.org/10.1097/MD.0000000000012056 |
Ejemplares similares
-
Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer
por: Alamgeer, Muhammad, et al.
Publicado: (2014) -
The Expression of Aldehyde Dehydrogenase Family in Breast Cancer
por: Qiu, Yan, et al.
Publicado: (2014) -
Diffuse optical spectroscopy for monitoring the responses of patients with breast cancer to neoadjuvant chemotherapy: A meta-analysis
por: Liu, Yong Hong, et al.
Publicado: (2018) -
Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review
por: Xu, Weilin, et al.
Publicado: (2020) -
Prognostic role of high neutrophil-to-lymphocyte ratio in breast cancer patients receiving neoadjuvant chemotherapy: Meta-analysis
por: Xue, Ling Bo, et al.
Publicado: (2019)